Cargando…

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients

AIM: To evaluate the influence of the presence of the killer cell immunoglobulin-like receptor (KIR) 3DS1 on HCV treatment response in HIV/HCV genotype 1 co-infected patients METHODS: HIV/HCV co-infected patients were included. KIR3DS1, their specific HLA-B ligands and IL28B gene were genotyped. Red...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivero-Juarez, Antonio, Gonzalez, Rafael, Camacho, Angela, Manzanares-Martin, Barbara, Caruz, Antonio, Martinez-Peinado, Antonio, Torre-Cisneros, Julian, Pineda, Juan A., Peña, José, Rivero, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629002/ https://www.ncbi.nlm.nih.gov/pubmed/23613999 http://dx.doi.org/10.1371/journal.pone.0061992

Ejemplares similares

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV
por: Rivero-Juárez, Antonio, et al.
Publicado: (2013)

HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2014)

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance
por: Frias, Mario, et al.
Publicado: (2018)

Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection
por: Real, Luis Miguel, et al.
Publicado: (2019)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

Frequency of Killer Cell Immunoglobulin-like Receptors (KIRs) in Korean Patients with Chronic HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2011)

HCV dsRNA-Activated Macrophages Inhibit HCV Replication in Hepatocytes
por: Wang, Yizhong, et al.
Publicado: (2015)

Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals
por: Rivero-Juárez, Antonio, et al.
Publicado: (2020)

Correlates of HCV seropositivity among familial contacts of HCV positive patients
por: La Torre, Giuseppe, et al.
Publicado: (2006)

What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis
por: Skaathun, Britt, et al.
Publicado: (2020)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients
por: Corchado, Sara, et al.
Publicado: (2014)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
por: Pellicelli, Adriano M, et al.
Publicado: (2012)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
por: Montes, Marisa, et al.
Publicado: (2014)

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection
por: Macías, Juan, et al.
Publicado: (2015)

Identification of the transcripts associated with spontaneous HCV clearance in individuals co-infected with HIV and HCV
por: Chen, Yue, et al.
Publicado: (2016)

Persistence of Pathological Distribution of NK Cells in HIV-Infected Patients with Prolonged Use of HAART and a Sustained Immune Response
por: Frias, Mario, et al.
Publicado: (2015)

The Relationship between Virological Characteristics of Hepatitis C Virus (HCV) and Reactivity to the Regional Specific Proteins of HCV(*)
por: Yoon, Seung Kew, et al.
Publicado: (2000)

Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR
por: Frías, Mario, et al.
Publicado: (2019)

The Natural Killer Cell Response to HCV Infection
por: Ahlenstiel, Golo
Publicado: (2013)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

Molecular Virology of Hepatitis C Virus (HCV): 2006 Update
por: Brass, Volker, et al.
Publicado: (2006)

Self-Association of an Activating Natural Killer Cell Receptor, KIR2DS1
por: Hayley, Michael, et al.
Publicado: (2011)

Liver Stiffness Using Transient Elastography is Applicable to Canines for Hepatic Disease Models
por: Rivero-Juárez, Antonio, et al.
Publicado: (2012)

Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy
por: Frias, Mario, et al.
Publicado: (2017)

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy
por: Muazzam, Ambreen G, et al.
Publicado: (2011)

HTLV-1 infection modulates the immune response in HIV-HCV coinfected patients and may increase spontaneous HCV clearance
por: Bahia, Fabianna, et al.
Publicado: (2014)

Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark
por: Mumdzhiev, Nikola Hristov, et al.
Publicado: (2019)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
por: Khattab, Mahmoud A., et al.
Publicado: (2022)

MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
por: Brochado-Kith, Óscar, et al.
Publicado: (2019)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study
por: Sacco, Rodolfo, et al.
Publicado: (2020)

KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes
por: Hoteit, R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ec7uc34oe8mv4j09bjql4c7v0v